Exactly, when you see all the parts and then the d
Post# of 36536
(Total Views: 251)
Posted On: 10/09/2020 10:46:09 AM
Exactly, when you see all the parts and then the deals, Generex is worth quite a bit and NGIO is worth quite a bit.
With or without a Covid vaccine, the value is there. Now, if something negative impacts a vaccine, it will impact the value , that's a given, but if there is positive news on the vaccine front, just think about how that value gets affected to NGIO and also to Generex. Look at the impact we have seen with other companies.
The potential with everything on their plate right now at this time is pretty amazing. In the middle of Covid and with businesses opening back up with their other revenue streams, now they can possibly move into action once again, Generex / NGIO are set to finally break out.
With or without a Covid vaccine, the value is there. Now, if something negative impacts a vaccine, it will impact the value , that's a given, but if there is positive news on the vaccine front, just think about how that value gets affected to NGIO and also to Generex. Look at the impact we have seen with other companies.
The potential with everything on their plate right now at this time is pretty amazing. In the middle of Covid and with businesses opening back up with their other revenue streams, now they can possibly move into action once again, Generex / NGIO are set to finally break out.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼